Early stage IT and Healthcare Investing

Trieza

portfoliocompanies

company snapshot

Trieza Therapeutics is a new company developing immunomodulatory oncolytic viruses for the treatment of cancer. Founded as a spinout from Potenza Therapeutics, Trieza has a portfolio containing multiple preclinical candidates.
website
Leadership
Follow The Company
Investment Team
Dan Hicklin, President & CEO
Facebook Google+ Twitter Email LinkedIn Share